Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 9:13 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1609–1632 of 2,516 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Apoplexy Clear all

Conditions: Atrial Fibrillation, Atrial Flutter, Stroke, Embolism, Systemic Arterial, Major Bleeding
Interventions: Home Monitoring Guided OAC, Physician-Directed OAC; Drug
Lead sponsor: Biotronik, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 2,718 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2013
U.S. locations: 73
States / cities: Phoenix, Arizona • Scottsdale, Arizona • Anaheim, California + 70 more

Conditions: Nonvalvular Atrial Fibrillation
Interventions: Rivaroxaban (Xarelto, BAY59-7939), Vitamin K antagonist (VKA); Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years and older
Enrollment: 78,517 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Multiple Locations, Washington

Conditions: Acute Stroke, Intracranial Hemorrhages, Subarachnoid Hemorrhage
Interventions: Not listed
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 21,646 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 9
States / cities: Asheville, North Carolina • Charlotte, North Carolina • Concord, North Carolina + 4 more

Conditions: Sickle Cell Disease
Interventions: Provider-level intervention, Patient-level intervention; Other
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 2 Years to 7 Years
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2023
U.S. locations: 15
States / cities: Little Rock, Arkansas • Oakland, California • Wilmington, Delaware + 10 more

Conditions: Neurogenic Bladder, Spinal Cord Injuries (Complete and Incomplete), Stroke, Multiple Sclerosis
Interventions: SCONE; Device
Lead sponsor: SpineX Inc.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 126 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 10
States / cities: Downey, California • San Diego, California • Denver, Colorado + 7 more

Conditions: Stroke, Acute, Ischemic Stroke
Interventions: Melatonin; Dietary Supplement
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 85 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Dysphagia, Stroke
Interventions: Microphone device; Device
Lead sponsor: Emory University; Other
Eligibility: 40 Years to 85 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 2
States / cities: Atlanta, Georgia

Conditions: Stroke
Interventions: Cognitive multisensory rehabilitation; Other
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years to 80 Years
Enrollment: 43 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2023
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Stroke
Interventions: Pre-pandemic stroke related metrics, Stroke related metrics during the pandemic; Other
Lead sponsor: Boston Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 345,089 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 2
States / cities: Atlanta, Georgia • Boston, Massachusetts

Conditions: Cerebrovascular Accident
Interventions: Not listed
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: Not listed
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2001 – 2004
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Stroke, Hemiparesis
Interventions: SynPhNe platform, Conventional therapy; Device · Other
Lead sponsor: Spaulding Rehabilitation Hospital; Other
Eligibility: 21 Years to 80 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Chronic Stroke Survivors, Chronic Stroke Patients, Stroke
Interventions: Robot-assisted gait training and transcutaneous spinal cord stimulation in chronic non-ambulatory stroke survivors: pilot RCT trial, Robot assisted gait training alone; Device
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 18 Years to 80 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Acute Stroke
Interventions: stretching and active movement training; Device
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 18 Years to 80 Years
Enrollment: 140 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2027
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Cerebrovascular Accident, Intracranial Hypertension
Interventions: 3-D ultrasound scanner, Perflutren Protein-Type A Microspheres for injection; Device · Drug
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 28 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2013
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Ataxia, Cerebrovascular Accident, Healthy, Movement Disorder, Tremor
Interventions: Not listed
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: Not listed
Enrollment: 510 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1992 – 2001
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Intracerebral Hemorrhage
Interventions: NXY-059; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years and older
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2006
U.S. locations: 64
States / cities: Birmingham, Alabama • Scottsdale, Arizona • Fort Smith, Arkansas + 61 more

Conditions: Stroke, Stroke, Acute, Stroke, Ischemic
Interventions: Endovascular Stroke Treatment, Medical Management; Procedure · Other
Lead sponsor: University of Cincinnati; Other
Eligibility: 18 Years and older
Enrollment: 1,060 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 35
States / cities: Birmingham, Alabama • Phoenix, Arizona • Los Angeles, California + 27 more

Conditions: Stroke
Interventions: Semantic Feature Analysis therapy, Phonomotor Therapy; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 58 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Clopidogrel Resistance, Secondary Stroke Prevention
Interventions: Primidone; Drug
Lead sponsor: Dent Neuroscience Research Center; Other
Eligibility: 18 Years to 90 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2013
U.S. locations: 1
States / cities: Amherst, New York

Conditions: Epilepsy, Seizure Disorder, Neurologic Disorder, Rare Diseases
Interventions: Clinical care and quality improvement; Other
Lead sponsor: Epilepsy Foundation of America; Other
Eligibility: Not listed
Enrollment: 100,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2099
U.S. locations: 13
States / cities: Phoenix, Arizona • Los Angeles, California • Aurora, Colorado + 7 more

Conditions: Stroke
Interventions: HandSOME; Device
Lead sponsor: The Catholic University of America; Other
Eligibility: 21 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Fabry Disease
Interventions: Replagal agalsidase alfa, Replagal; Drug
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: 39 Years to 45 Years · Male only
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2003
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Stroke
Interventions: Operant conditioning of motor evoked potentials; Other
Lead sponsor: University of Houston; Other
Eligibility: 40 Years to 75 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Cardiovascular Disease
Interventions: bococizumab (PF-04950615), Placebo; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years and older
Enrollment: 16,784 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 545
States / cities: Athens, Alabama • Birmingham, Alabama • Fort Payne, Alabama + 339 more

Search by objective public record fields.

Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk

Rivaroxaban vs Warfarin for SPAF in Multi-morbid Patients

IMPROVE Stroke Care- Developing and Optimizing Regional Systems of Stroke Care

Dissemination and Implementation of Stroke Prevention Looking at the Care Environment

Spinal COrd NeuromodulaTor by SpIneX and ScoNE to Treat NeurogeniC BladdEr - SCONE "CONTINENCE" Clinical Study

Melatonin in Acute Stroke

Dysphagia Study Using Novel Microphone Device

Functional Connectivity In Relation To Proprioception and Sensorimotor Recovery in Stroke Patients (Feasibility Study)

Global Impact of the COVID 19 Pandemic on Stroke Care, Cerebral Venous Thrombosis, and Subarachnoid Hemorrhage

Role of the Intact Hemisphere in Recovery of Motor Function After Stroke

Assessment of a Physio-neuro Platform (SynPhNe) for Home-based Retraining of Hand Function in Stroke Survivors

Walking and tSCS in Non-ambulatory Stroke Survivors

Sensory-Motor Rehabilitation Post Stroke

3-D Transcranial Ultrasound Analysis Study

PET Scan to Study Brain Control of Human Movement

Safety of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke

Treatment With Endovascular Intervention for STroke Patients With Existing Disability

Speech Therapy for Aphasia: Comparing Two Treatments

Effect of Primidone on Platelet Responsiveness in Patients Determined to be Clopidogrel Resistant

Epilepsy Learning Healthcare System (ELHS)

Home Therapy for Stroke Rehabilitation Using the HandSOME Exoskeleton

An Open-Label Maintenance Study of the Enzyme Replacement Therapy Replagal in Patients With Fabry Disease

Operant Conditioning for Rehabilitation After Stroke

The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects